In gastric cancer, PPARD overexpression in genetically engineered mice induces invasive adenocarcinoma and chronic inflammation, highlighting its therapeutic potential but necessitating further investigation into its role in metabolism and tumor microenvironment modulation [15]. Here, PPARD is linked to neoplasm.